MedTrace Logo

Long Term Outcomes of Vivity Intra Ocular Lens(IOL) Versus Control

NCT04561570 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2023-08-01

No results posted yet for this study

Summary

Evaluate the long-term (\>1 yr) outcomes of the Vivity IOL. The investigator will use similar measurements and procedures to the ones performed on these subjects during the FDA clinical trial.

Conditions

  • Cataract

Interventions

DEVICE

Vivity ACRYSOF IQ IOL Group

Subjects that were implanted with the Vivity ACRYSOF IQ extended depth of focus IntaOcular Lens

DEVICE

ACRYSOF IQ IOL Control Group

Subject that were implanted with the ACRYSOF IQ Monofocal IntaOcular Lens

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • The Eye Associates

    collaborator OTHER

  • Eye Care Specialists

    collaborator UNKNOWN

  • NewsomeEye

    collaborator UNKNOWN

  • John Berdahl, MD

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-17
Primary Completion
2021-04-27
Completion
2021-04-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04561570 on ClinicalTrials.gov